Pacira Pharmaceuticals reported $7.33M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 538K 76K
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Aerie Pharmaceuticals AERI:US $ 7.36M 0.24M
Bristol Myers Squibb BMY:US $ 328M 2M
Coherus Biosciences CHRS:US $ 5.77M 0.02M
Depomed DEPO:US $ 2.5M 0.11M
Endo International Ordinary Shares ENDP:US $ 142.99M 1.35M
Flexion Therapeutics FLXN:US $ 6.29M 1.11M
Ironwood Pharmaceuticals IRWD:US $ 7.84M 0.11M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Lannett LCI:US $ 14.22M 1.01M
Ligand Pharmaceuticals LGND:US $ 4.44M 0.44M
Nektar Therapeutics NKTR:US $ 12.8M 0.29M
Omeros OMER:US $ 4.91M 1000
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Pfizer PFE:US $ 325M 9M
Revance Therapeutics RVNC:US $ 1.57M 2K
Supernus Pharmaceuticals SUPN:US $ 5.92M 1.43M
Teva Pharmaceutical TEVA:IT 232M 8M
Xeris Pharmaceuticals Inc XERS:US $ 1.8M 3K
Xoma XOMA:US $ 0 172K
Zoetis ZTS:US $ 56M 1M